Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124


Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population.

Kannabiran C, Ueta M, Sangwan V, Rathi V, Basu S, Tokunaga K, Kinoshita S.

Sci Rep. 2017 Nov 21;7(1):15960. doi: 10.1038/s41598-017-15965-7.


Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases.

Multidisciplinary Expert Task Force on Hyperuricemia and Related Diseases.

Chin Med J (Engl). 2017 Oct 20;130(20):2473-2488. doi: 10.4103/0366-6999.216416. No abstract available.


Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions.

Ueta M.

Taiwan J Ophthalmol. 2016 Jul-Sep;6(3):108-118. doi: 10.1016/j.tjo.2016.06.001. Epub 2016 Aug 6. Review.


Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Pavlos R, White KD, Wanjalla C, Mallal SA, Phillips EJ.

Immunol Allergy Clin North Am. 2017 Nov;37(4):785-815. doi: 10.1016/j.iac.2017.07.007. Review.


Gout: An old disease in new perspective - A review.

Ragab G, Elshahaly M, Bardin T.

J Adv Res. 2017 Sep;8(5):495-511. doi: 10.1016/j.jare.2017.04.008. Epub 2017 May 10. Review.


Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT).

Karnes JH, Shaffer CM, Cronin R, Bastarache L, Gaudieri S, James I, Pavlos R, Steiner HE, Mosley JD, Mallal S, Denny JC, Phillips EJ, Roden DM.

Pharmacotherapy. 2017 Sep;37(9):1164-1171. doi: 10.1002/phar.1983. Epub 2017 Sep 4.


Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.

Cho YT, Yang CW, Chu CY.

Int J Mol Sci. 2017 Jun 9;18(6). pii: E1243. doi: 10.3390/ijms18061243. Review.


The genetics of gout: towards personalised medicine?

Dalbeth N, Stamp LK, Merriman TR.

BMC Med. 2017 May 31;15(1):108. doi: 10.1186/s12916-017-0878-5. Review.


Acute severe liver dysfunction induced by febuxostat in a patient undergoing hemodialysis.

Ito K, Ueda Y, Miyazawa H, Kaku Y, Hirai K, Hoshino T, Nabata A, Mori H, Yoshida I, Ookawara S, Tabei K.

CEN Case Rep. 2014 Nov;3(2):158-161. doi: 10.1007/s13730-014-0109-2. Epub 2014 Feb 15.


Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Peter JG, Lehloenya R, Dlamini S, Risma K, White KD, Konvinse KC, Phillips EJ.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):547-563. doi: 10.1016/j.jaip.2017.01.025.


HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions.

Shi YW, Min FL, Zhou D, Qin B, Wang J, Hu FY, Cheung YK, Zhou JH, Hu XS, Zhou JQ, Zhou LM, Zheng ZZ, Pan J, He N, Liu ZS, Hou YQ, Lim KS, Ou YM, Hui-Ping Khor A, Ng CC, Mao BJ, Liu XR, Li BM, Kuan YY, Yi YH, He XL, Deng XY, Su T, Kwan P, Liao WP.

Neurology. 2017 Jun 6;88(23):2183-2191. doi: 10.1212/WNL.0000000000004008. Epub 2017 May 5.


Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest.

Pappas DJ, Lizee A, Paunic V, Beutner KR, Motyer A, Vukcevic D, Leslie S, Biesiada J, Meller J, Taylor KD, Zheng X, Zhao LP, Gourraud PA, Hollenbach JA, Mack SJ, Maiers M.

Pharmacogenomics J. 2017 Apr 25. doi: 10.1038/tpj.2017.7. [Epub ahead of print]


Recent advances in understanding and managing gout.

Igel TF, Krasnokutsky S, Pillinger MH.

F1000Res. 2017 Mar 10;6:247. doi: 10.12688/f1000research.9402.1. eCollection 2017. Review.


Pharmacogenomics of off-target adverse drug reactions.

Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA Jr, Phillips EJ.

Br J Clin Pharmacol. 2017 Sep;83(9):1896-1911. doi: 10.1111/bcp.13294. Epub 2017 Apr 27. Review.


Multiple Drug Hypersensitivity.

Pichler WJ, Srinoulprasert Y, Yun J, Hausmann O.

Int Arch Allergy Immunol. 2017;172(3):129-138. doi: 10.1159/000458725. Epub 2017 Mar 18. Review.


Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.

Van Den Driessche G, Fourches D.

J Cheminform. 2017 Mar 4;9:13. doi: 10.1186/s13321-017-0202-6. eCollection 2017.


Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.

Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, Park M, Blumenthal K, Aberer W, Castells M, Barbaud A, Mayorga C, Bonadonna P.

Clin Transl Allergy. 2017 Mar 13;7:7. doi: 10.1186/s13601-017-0144-0. eCollection 2017. Review.


Stevens-Johnson syndrome and abuse of anabolic steroids.

Cocca S, Viviano M.

J Korean Assoc Oral Maxillofac Surg. 2017 Feb;43(1):57-60. doi: 10.5125/jkaoms.2017.43.1.57. Epub 2017 Feb 20.


Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.

Wakamatsu TH, Ueta M, Tokunaga K, Okada Y, Loureiro RR, Costa KA, Sallum JMF, Milhomens JA, Inoue C, Sotozono C, Gomes JÁP, Kinoshita S.

JAMA Ophthalmol. 2017 Apr 1;135(4):355-360. doi: 10.1001/jamaophthalmol.2017.0074.


Recent advances in the understanding of severe cutaneous adverse reactions.

Adler NR, Aung AK, Ergen EN, Trubiano J, Goh MSY, Phillips EJ.

Br J Dermatol. 2017 Nov;177(5):1234-1247. doi: 10.1111/bjd.15423. Epub 2017 Sep 29. Review.


Supplemental Content

Support Center